| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00280-011-1563-6 |
| P698 | PubMed publication ID | 21290245 |
| P2093 | author name string | Wenhui Li | |
| Dan Sun | |||
| Jing Zhao | |||
| Shasha Wang | |||
| Yan Xin | |||
| Hongju Wu | |||
| Yueyun Hu | |||
| P2860 | cites work | Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice | Q33485606 |
| Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. | Q34633187 | ||
| The anti-angiogenic basis of metronomic chemotherapy | Q35788112 | ||
| CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells | Q36276395 | ||
| Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy | Q36689936 | ||
| Vascular endothelial growth factor and bevacitumab in breast cancer | Q36814232 | ||
| Angiogenesis as targeted breast cancer therapy | Q36913981 | ||
| Review of docetaxel in the treatment of gastric cancer | Q37052880 | ||
| Metronomic chemotherapy: changing the paradigm that more is better | Q37158779 | ||
| New drugs in the treatment of gastric tumors | Q37167946 | ||
| Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib | Q38572743 | ||
| Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration | Q40237701 | ||
| Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer | Q40253380 | ||
| Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player | Q46075605 | ||
| Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts | Q46076079 | ||
| Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts | Q46638664 | ||
| Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model | Q46696495 | ||
| Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. | Q46830983 | ||
| Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma | Q46962116 | ||
| P433 | issue | 4 | |
| P921 | main subject | docetaxel | Q420436 |
| P304 | page(s) | 879-887 | |
| P577 | publication date | 2011-02-03 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model. | |
| P478 | volume | 68 |
| Q37337814 | Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). |
| Q90650691 | CCL2 influences the sensitivity of lung cancer A549 cells to docetaxel |
| Q64101438 | Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia-inducible factor 1α axis |
| Q38087885 | Metronomic chemotherapy for cancer treatment: a decade of clinical studies |
| Q40036535 | Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation |
| Q24635643 | Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma |
| Q38489591 | Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy |
Search more.